Have a personal or library account? Click to login
Identification of peptide and protein doping related drug compounds confiscated in Denmark between 2007-2013 Cover

Identification of peptide and protein doping related drug compounds confiscated in Denmark between 2007-2013

Scandinavian Journal of Forensic Science
Volume 20 (2014): Issue 2 (December 2014)
By: Rune Andersen Hartvig,  Niels Bjerre Holm,  Petur Weihe Dalsgaard,  Lotte Ask Reitzel,  Irene Breum Müller and  Kristian Linnet  
Open Access
|Mar 2015

References

  1. [1] Vlieghe P., Lisowski, V., Martinez, J., Khrestchatisky, M., Synthetic therapeutic peptides: science and market, Drug Discovery Today., 2010, 15, 40-5610.1016/j.drudis.2009.10.00919879957
    Search in Google Scholar
  2. [2] Lawrence S., Biotech blockbusters consolidate markets, Nat.Biotechnol., 2006, 24, 146610.1038/nbt1206-146617160033
    Search in Google Scholar
  3. [3] Kohler M., Thomas, A., Geyer, H., Petrou, M., Schänzer, W., Thevis, M., Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the cologne doping control laboratory 2009, Drug Test Analysis., 2010, 2, 533-53710.1002/dta.18621204286
    Search in Google Scholar
  4. [4] Jetté L., Léger, R., Thibaudeau, K., Benquet, C., Robitaille, M., Pellerin, I.et al., Human Growth Hormone-Releasing Factor (hGRF)1−29-Albumin Bioconjugates Activate the GRF Receptor on the Anterior Pituitary in Rats: Identification of CJC-1295 as a Long-Lasting GRF Analog, Endocrinology., 2005, 146, 3052-305810.1210/en.2004-128615817669
    Search in Google Scholar
  5. [5] Patient Died in Lipodystrophy Drug Study, http://www.natap.org/2006/newsUpdates/081106_02.htm
    Search in Google Scholar
  6. [6] A Study to Evaluate CJC 1295 in HIV Patients With Visceral Obesity, http://clinicaltrials.gov/ct2/show/NCT00267527
    Search in Google Scholar
  7. [7] Thevis M., Loo, J. A., Loo, R. R. O., Schänzer, W., Recommended criteria for the mass spectrometric identification of target peptides and proteins (<kDa) in sports drug testing, Rapid Commun.Mass Spectrom., 2007, 21, 297-30410.1002/rcm.284817200979
    Search in Google Scholar
  8. [8] Mallick P., Schirle, M., Chen, S. S., Flory, M. R., Lee, H., Martin, D.et al., Computational prediction of proteotypic peptides for quantitative proteomics, Nat.Biotechnol., 2007, 25, 125-13110.1038/nbt127517195840
    Search in Google Scholar
  9. [9] Thomas A., Kohler, M., Mester, J., Geyer, H., Schanzer, W., Petrou, M.et al., Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement, Drug Test.Anal., 2010, 2, 144-14810.1002/dta.12020878896
    Search in Google Scholar
  10. [10] Thomas A., Höppner, S., Geyer, H., Schänzer, W., Petrou, M., Kwiatkowska, D.et al., Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry, Anal Bioanal Chem., 2011, 401, 507-51610.1007/s00216-011-4702-321298258
    Search in Google Scholar
  11. [11] Thevis M., Mass Spectrometry in Sports Drug Testing: Characterization of Prohibited Substances and Doping Control Analytical Assays., 2010, 4910.1002/9780470626634
    Search in Google Scholar
  12. [12] Henninge J., Pepaj, M., Hullstein, I., Hemmersbach, P., Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation, Drug Test Analysis., 2010, 2, 647-65010.1002/dta.23321204297
    Search in Google Scholar
  13. [13] Mock S., Shen, X., Tamvakopoulos, C., Determination of melanotan-II in rat plasma by liquid chromatography/tandem mass spectrometry: determination of pharmacokinetic parameters in rat following intravenous administration, Rapid Commun. Mass Spectrom., 2002, 16, 2142-214710.1002/rcm.847
    Search in Google Scholar
  14. [14] Tamvakopoulos C., Mass spectrometry for the quantification of bioactive peptides in biological fluids, Mass Spectrom.Rev., 2007, 26, 389-40210.1002/mas.20120
    Search in Google Scholar
  15. [15] Hatziieremia S., Kostomitsopoulos, N., Balafas, V., Tamvakopoulos, C., A liquid chromatographic/tandem mass spectroscopic method for quantification of the cyclic peptide melanotan-II. Plasma and brain tissue concentrations following administration in mice, Rapid Commun.Mass Spectrom., 2007, 21, 2431-243810.1002/rcm.3106
    Search in Google Scholar
  16. [16] Popot M. A., Woolfitt, A. R., Garcia, P., Tabet, J. C., Determination of IGF-I in horse plasma by LC electrospray ionisation mass spectrometry, Anal Bioanal Chem., 2008, 390, 1843-185210.1007/s00216-008-1889-z
    Search in Google Scholar
  17. [17] Kay R., Halsall, D. J., Annamalai, A. K., Kandasamy, N., Taylor, K., Fenwick, S.et al., A novel mass spectrometry-based method for determining insulin-like growth factor 1: assessment in a cohort of subjects with newly diagnosed acromegaly, Clin Endocrinol., 2013, 78, 424-43010.1111/cen.12085
    Search in Google Scholar
  18. [18] Bredehöft M., Schänzer, W., Thevis, M., Quantification of human insulin-like growth factor-1 and qualitative detection of its analogues in plasma using liquid chromatography/electrospray ionisation tandem mass spectrometry, Rapid Commun. Mass Spectrom., 2008, 22, 477-48510.1002/rcm.3388
    Search in Google Scholar
  19. [19] Thevis M., Bredehöft, M., Kohler, M., Schänzer, W., Mass Spectrometry-Based Analysis of IGF-1 and hGH., 2010, 195, 201-20710.1007/978-3-540-79088-4_9
    Search in Google Scholar
  20. [20] Gam L. H., Tham, S. Y., Latiff, A., Immunoaffinity extraction and tandem mass spectrometric analysis of human chorionic gonadotropin in doping analysis, Journal of Chromatography B., 2003, 792, 187-19610.1016/S1570-0232(03)00264-2
    Search in Google Scholar
  21. [21] Liu C. and Bowers, L. D., Mass spectrometric characterization of the beta-subunit of human chorionic gonadotropin, J.Mass Spectrom., 1997, 32, 33-4210.1002/(SICI)1096-9888(199701)32:1<;33::AID-JMS446>3.0.CO;2-X
    Search in Google Scholar
  22. [22] Morten Bødskov., Forslag til lov om ændring af straffeloven., L 8, 2-10-2013, http://www.ft.dk/RIpdf/samling/20131/lovforslag/L8/20131_L8_som_vedtaget. pd
    Search in Google Scholar
DOI: https://doi.org/10.2478/sjfs-2014-0003 | Journal eISSN: 2353-0707
Journal RSS Feed
Language: English
Page range: 42 - 49
Published on: Mar 3, 2015
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Black market drugs,
doping,
screening,
peptides,
hormones,
proteins,
mass spectrometry,
high-resolution MS
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2015 Rune Andersen Hartvig, Niels Bjerre Holm, Petur Weihe Dalsgaard, Lotte Ask Reitzel, Irene Breum Müller, Kristian Linnet, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 20 (2014): Issue 2 (December 2014)Next article